Jennison Associates LLC Buys 11,651 Shares of Shockwave Medical, Inc. (NASDAQ:SWAV)

Jennison Associates LLC grew its stake in Shockwave Medical, Inc. (NASDAQ:SWAVFree Report) by 13.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 100,551 shares of the company’s stock after acquiring an additional 11,651 shares during the period. Jennison Associates LLC’s holdings in Shockwave Medical were worth $19,161,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the stock. Lindbrook Capital LLC increased its position in Shockwave Medical by 64.8% during the third quarter. Lindbrook Capital LLC now owns 150 shares of the company’s stock worth $30,000 after acquiring an additional 59 shares during the period. EverSource Wealth Advisors LLC increased its position in Shockwave Medical by 297.4% during the third quarter. EverSource Wealth Advisors LLC now owns 155 shares of the company’s stock worth $31,000 after acquiring an additional 116 shares during the period. Asset Management One Co. Ltd. acquired a new stake in Shockwave Medical during the fourth quarter worth about $34,000. Operose Advisors LLC acquired a new stake in Shockwave Medical during the third quarter worth about $49,000. Finally, Venturi Wealth Management LLC acquired a new stake in Shockwave Medical during the third quarter worth about $82,000. 95.35% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Frederic H. Moll sold 60,000 shares of Shockwave Medical stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $257.39, for a total value of $15,443,400.00. Following the completion of the sale, the director now owns 287,521 shares in the company, valued at approximately $74,005,030.19. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, VP Trinh Phung sold 599 shares of the business’s stock in a transaction dated Thursday, February 22nd. The stock was sold at an average price of $259.24, for a total value of $155,284.76. Following the sale, the vice president now directly owns 31,031 shares in the company, valued at approximately $8,044,476.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Frederic H. Moll sold 60,000 shares of the business’s stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $257.39, for a total value of $15,443,400.00. Following the completion of the sale, the director now owns 287,521 shares in the company, valued at $74,005,030.19. The disclosure for this sale can be found here. Insiders sold 89,813 shares of company stock worth $22,863,919 in the last quarter. 3.40% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

SWAV has been the topic of a number of analyst reports. Needham & Company LLC reiterated a “hold” rating on shares of Shockwave Medical in a research note on Friday, April 5th. Canaccord Genuity Group restated a “hold” rating and issued a $335.00 price target (up from $263.00) on shares of Shockwave Medical in a research note on Friday, April 5th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $335.00 target price (up from $270.00) on shares of Shockwave Medical in a research report on Monday, April 8th. TheStreet upgraded shares of Shockwave Medical from a “c+” rating to a “b” rating in a research report on Thursday, February 15th. Finally, Morgan Stanley reiterated an “equal weight” rating and set a $335.00 target price (up from $285.00) on shares of Shockwave Medical in a research report on Monday, April 8th. Ten equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $309.11.

Get Our Latest Stock Analysis on Shockwave Medical

Shockwave Medical Stock Up 0.0 %

Shockwave Medical stock opened at $328.99 on Friday. The company has a debt-to-equity ratio of 1.09, a quick ratio of 10.73 and a current ratio of 11.76. Shockwave Medical, Inc. has a 52-week low of $157.00 and a 52-week high of $331.58. The firm has a 50 day moving average price of $293.53 and a two-hundred day moving average price of $232.36. The firm has a market cap of $12.30 billion, a price-to-earnings ratio of 85.01, a PEG ratio of 2.44 and a beta of 0.92.

Shockwave Medical (NASDAQ:SWAVGet Free Report) last released its quarterly earnings data on Thursday, February 15th. The company reported $1.16 earnings per share for the quarter, beating the consensus estimate of $0.92 by $0.24. The company had revenue of $202.98 million during the quarter, compared to analyst estimates of $199.43 million. Shockwave Medical had a net margin of 20.17% and a return on equity of 23.97%. Shockwave Medical’s revenue for the quarter was up 41.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.71 EPS. Equities analysts predict that Shockwave Medical, Inc. will post 4.94 EPS for the current year.

Shockwave Medical Profile

(Free Report)

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.

Featured Articles

Want to see what other hedge funds are holding SWAV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shockwave Medical, Inc. (NASDAQ:SWAVFree Report).

Institutional Ownership by Quarter for Shockwave Medical (NASDAQ:SWAV)

Receive News & Ratings for Shockwave Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shockwave Medical and related companies with MarketBeat.com's FREE daily email newsletter.